The microbiome of patients experiencing recurrent CDI is frequently dominated by overgrowths of Enterococcus species This study evaluated the in vitro bactericidal and molecular efficacy of ibezapolstat (IBZ), vancomycin (VAN), and fidaxomicin (FDX) against C. difficile and Enterococcus...
Hence then, the article about acurx announces presentation of a scientific poster at the premier international c difficile symposium icds demonstrating superior in vitro kill kinetics of ibezapolstat vs vancomycin and fidaxomicin standards of care in clostridioide was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. Vancomycin and Fidaxomicin (Standards of Care) in Clostridioide )
Also on site :
- In 1989, Exxon accidentally spilled 11 million gallons of oil into Alaska’s Prince William Sound; the Supreme Court later cut its $2.5 billion fine to $500 million
- How to Watch Levante vs Atletico Madrid Live: Full Match Details
- Elvis’ Granddaughter Watches as Harry Styles Pays Tribute to the King With Elvis-Inspired Halloween Costume During Concert